PTGER4 and tumor of uterus: Based on the presence of both cytoplasmic and nuclear immunoreactivity of EP4 in patient uterine tumor samples, class III β-tubulin and EP4 protein expression within the cytoplasmic and nuclear fractions of PHM1-41, SK-UT-1, and SK-UT-1B were also evaluated (Figure 4C).